# FDA Inspection 1166989 - Global Blood Therapeutics, Inc. - March 11, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/global-blood-therapeutics-inc/6d0a2061-57d0-4f23-b9c0-446bc6562e4b
Source feed: FDA_Inspections

> FDA Inspection 1166989 for Global Blood Therapeutics, Inc. on March 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166989
- Company Name: Global Blood Therapeutics, Inc.
- Inspection Date: 2022-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1099869 - 2019-08-12](https://www.globalkeysolutions.net/records/fda_inspections/global-blood-therapeutics-inc/3880f868-7c1a-48bc-9715-728cfe0af622)

Company: https://www.globalkeysolutions.net/companies/global-blood-therapeutics-inc/f8d23240-2082-4157-b284-c0372b4037fb

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c